Sustainable Development Goals can be reached ‘despite our grim times’: ECOSOC President
Collen V. Kelapile, President of the Economic and Social Council (ECOSOC), was delivering opening remarks to the ministerial segment of...
Vaccines
COVID hospitalizations forecast to increase amid concerns over new omicron subvariants
For the first time since May, COVID-19-related hospital admissions are forecasted to increase again in the U.S., as highly infectious...
Opinion: Why parents need to vaccinate young children against COVID-19
As I sat in the vaccine clinic last year, rolling up my sleeve, I felt a small pop in my...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/KFLIWB3XEZN7JLETY5TWAGKWFA.jpg "Adapted, two-strain vaccines to lift COVID protection")
Adapted, two-strain vaccines to lift COVID protection
FRANKFURT/LONDON, July 13 (Reuters) - Adapted versions of established mRNA COVID-19 vaccines that address two variants in one shot will...
F.D.A. Authorizes Novavax’s Covid-19 Vaccine, a Latecomer
The Food and Drug Administration on Wednesday authorized a Covid-19 vaccine developed by Novavax, a biotechnology company in Maryland that...
It’s time to start paying more attention to Covid-19 again
A version of this story appears in CNN's What Matters newsletter. To get it in your inbox, sign up for...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/HB4G5YE3WBN4FBFQSMM44TWS7Y.jpg "U.S. FDA authorizes Novavax COVID vaccine for adults")
U.S. FDA authorizes Novavax COVID vaccine for adults
July 13 (Reuters) - The U.S. Food and Drug Administration authorized the use of Novavax Inc's (NVAX.O) COVID-19 vaccine on...
FDA authorizes Novavax’s Covid vaccine
The Food and Drug Administration on Wednesday authorized Novavax’s protein-based Covid vaccine for adults, providing Americans with an alternative to...
COVID-19 Reinfections Are Common—And They Aren’t Harmless
By now, you may know—or be—someone who has had COVID-19 two, three, or even four times. Omicron and its subvariants,...
FDA gives emergency use authorization to Novavax’s Covid-19 vaccine
Novavax's vaccine will be available as two-dose primary series for people 18 and older. The FDA's independent Vaccines and Related...